NSRX Stock Chart & Stats
$4.10
$0.07(2.31%)
At close: 4:00 PM EDT
$4.10
$0.07(2.31%)
Day’s Range― - ―
52-Week Range$1.98 - $9.50
Previous CloseN/A
Volume11.90K
Average Volume (3M)17.67K
Market Cap
$38.88M
Enterprise Value$34.79M
Total Cash (Recent Filing)$11.82M
Total Debt (Recent Filing)$103.00K
Price to Earnings (P/E)―
Beta1.21
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding11,710,808
10 Day Avg. Volume33,499
30 Day Avg. Volume17,670
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)26.48
Price to Sales (P/S)0.00
P/FCF Ratio-14.86
Enterprise Value/Market Cap0.89
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-4.84
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Nasus Pharma Ltd. News
NSRX FAQ
What was Nasus Pharma Ltd.’s price range in the past 12 months?
Nasus Pharma Ltd. lowest stock price was $1.98 and its highest was $9.50 in the past 12 months.
What is Nasus Pharma Ltd.’s market cap?
Nasus Pharma Ltd.’s market cap is $38.88M.
When is Nasus Pharma Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nasus Pharma Ltd.’s earnings last quarter?
Currently, no data Available
Is Nasus Pharma Ltd. overvalued?
According to Wall Street analysts Nasus Pharma Ltd.’s price is currently Overvalued.
Does Nasus Pharma Ltd. pay dividends?
Nasus Pharma Ltd. does not currently pay dividends.
What is Nasus Pharma Ltd.’s EPS estimate?
Nasus Pharma Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nasus Pharma Ltd. have?
Nasus Pharma Ltd. has 11,710,808 shares outstanding.
What happened to Nasus Pharma Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nasus Pharma Ltd.?
Currently, no hedge funds are holding shares in NSRX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nasus Pharma Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
NSRX Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-56.88%
12-Months-Change
Fundamentals
Return on Equity
-158.83%
Trailing 12-Months
Asset Growth
2101.94%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Nasus Pharma Ltd.
Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats. The company's products include NS002, Intranasal Epinephrine for assisting in severe allergic reaction emergency situations and NS001, an Intranasal Naloxone powder nasal spray for the treatment of opioid overdose. Nasus Pharma Ltd. was incorporated in 2019 and is based in Tel Aviv-Yafo, Israel.